BD's (BDX) latest partnership is likely to aid cytotechnologists and pathologists to efficiently identify evidence of cervical cancer and pre-cancerous lesions.
Continued strength in BD's (BDX) Life Sciences segment's base business is expected to have benefited fiscal first-quarter sales.
Becton, Dickinson and Company (BDX) partners with Hamilton to boost its portfolio of single-cell multiomics solutions, enabling researchers to perform more confident experiments.
Becton Dickinson (BDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Becton, Dickinson and Company has underperformed the market and healthcare sector in recent years. The company's balance sheet has improved significantly which I believe will allow for increased retur
Becton Dickinson Chairman, President and CEO Tom Polen joins 'Mad Money' host Jim Cramer to talk inflation's impact on healthcare, the prefilled syringe market and more.
Becton Dickinson Chairman, President and CEO Tom Polen joins 'Mad Money' host Jim Cramer to talk inflation's impact on healthcare, the prefilled syringe market and more.
FRANKLIN LAKES, N.J. , Jan. 5, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host a live webcast of its
FRANKLIN LAKES, N.J., Jan. 4, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results f
The S&P 500 Dividend Aristocrats Index contains 67 dividend growth stocks called the Dividend Aristocrats.
FRANKLIN LAKES, N.J., Dec. 22, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 42nd Annual

Bear of the Day: Becton, Dickenson and Co (BDX)

08:16am, Tuesday, 12'th Dec 2023
Earnings have been retreating on this Bear of the Day.

New Strong Sell Stocks for December 11th

06:46am, Monday, 11'th Dec 2023
DG, BDX and CIGI have been added to the Zacks Rank #5 (Strong Sell) List on December 11, 2023.
BD's (BDX) FDA approval for MiniDraw will likely reshape diagnostic testing by providing a unique design that offers blood collection at any convenient location with reduced volume.
Becton Dickinson said on Thursday the U.S. Food and Drug Administration (FDA) had cleared its less invasive blood collection device.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE